Skip to main navigation Skip to search Skip to main content

Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells

  • Gabriela Riemekasten*
  • , Dirk Langnickel
  • , Philipp Enghard
  • , Reinmar Undeutsch
  • , Jens Humrich
  • , Fanny M. Ebling
  • , Berthold Hocher
  • , Tiina Humaljoki
  • , Hans Neumayer
  • , Gerd R. Burmester
  • , Bevra H. Hahn
  • , Andreas Radbruch
  • , Falk Hiepe
  • *Corresponding author for this work
  • Charite - Universitatsmedizin Berlin
  • California State University Los Angeles
  • German Rheumatism Research Centre (Leibniz Institute)

Abstract

T cells that recognize nucleoproteins are required for the production of anti-dsDNA Abs involved in lupus development. SmD183-119(a D1 protein of the Smith (Sm) proteins, part of small nuclear ribonucleoprotein) was recently shown to provide T cell help to anti-dsDNA Abs in the NZB/NZW model of lupus. Using this model in the present study, we showed that high dose tolerance to SmD1 (600-1000 μg i.v. of SmD183-119peptide/mo) delays the production of autoantibodies, postpones the onset of lupus nephritis as confirmed by histology, and prolongs survival. Tolerance to SmD1 83-119 was adoptively transferred by CD90+ T cells, which also reduce T cell help for autoreactive B cells in vitro. One week after SmD183-119 tolerance induction in prenephritic mice, we detected cytokine changes in cultures of CD90+ T and B22O+ B cells with decreased IFN-γ and IL-4 expression and an increase in TGFβ. Increased frequencies of regulatory IFN-γ+ and IL10+ CD4+ T cells were later detected. Such regulatory IL-10 +/IFN-γ+ type 1 regulatory T cells prevented autoantibody generation and anti-CD3-induced proliferation of naive T cells. In conclusion, these results indicate that SmD183-119 peptide may play a dominant role in the activation of helper and regulatory T cells that influence autoantibody generation and murine lupus.

Original languageEnglish
JournalJournal of Immunology
Volume173
Issue number9
Pages (from-to)5835-5842
Number of pages8
ISSN0022-1767
DOIs
Publication statusPublished - 01.11.2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells'. Together they form a unique fingerprint.

Cite this